BRPI0909211B8 - formulação oral em forma de comprimido de compostos de tetraciclina - Google Patents

formulação oral em forma de comprimido de compostos de tetraciclina

Info

Publication number
BRPI0909211B8
BRPI0909211B8 BRPI0909211A BRPI0909211A BRPI0909211B8 BR PI0909211 B8 BRPI0909211 B8 BR PI0909211B8 BR PI0909211 A BRPI0909211 A BR PI0909211A BR PI0909211 A BRPI0909211 A BR PI0909211A BR PI0909211 B8 BRPI0909211 B8 BR PI0909211B8
Authority
BR
Brazil
Prior art keywords
tetracycline compounds
oral tablet
form formulation
oral
formulations
Prior art date
Application number
BRPI0909211A
Other languages
English (en)
Inventor
Johnston Sean
Original Assignee
Paratek Pharm Innc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41114256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0909211(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Paratek Pharm Innc filed Critical Paratek Pharm Innc
Priority to BR122020011180A priority Critical patent/BR122020011180B8/pt
Publication of BRPI0909211A2 publication Critical patent/BRPI0909211A2/pt
Publication of BRPI0909211B1 publication Critical patent/BRPI0909211B1/pt
Publication of BRPI0909211B8 publication Critical patent/BRPI0909211B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

formulações orais e injetáveis de compostos de tetraciclina são descritas formulações injetáveis e orais de um composto de tetraciclina. em uma modalidade, a invenção se refere a uma formulação oral de um composto de 9-aminometil tetraciclina, ou de um sal seu, em forma de comprimido ou cápsula. as formulações po-dem ser usadas, por exemplo, para tratar infecções.
BRPI0909211A 2008-03-28 2009-03-30 formulação oral em forma de comprimido de compostos de tetraciclina BRPI0909211B8 (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR122020011180A BR122020011180B8 (pt) 2008-03-28 2009-03-30 formulações injetáveis de compostos de tetraciclina

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4039808P 2008-03-28 2008-03-28
US61/040,398 2008-03-28
PCT/US2009/001973 WO2009120389A1 (en) 2008-03-28 2009-03-30 Oral and injectable formulations of tetracycline compounds

Publications (3)

Publication Number Publication Date
BRPI0909211A2 BRPI0909211A2 (pt) 2016-11-29
BRPI0909211B1 BRPI0909211B1 (pt) 2020-08-25
BRPI0909211B8 true BRPI0909211B8 (pt) 2021-05-25

Family

ID=41114256

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0909211A BRPI0909211B8 (pt) 2008-03-28 2009-03-30 formulação oral em forma de comprimido de compostos de tetraciclina
BR122020011180A BR122020011180B8 (pt) 2008-03-28 2009-03-30 formulações injetáveis de compostos de tetraciclina

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR122020011180A BR122020011180B8 (pt) 2008-03-28 2009-03-30 formulações injetáveis de compostos de tetraciclina

Country Status (30)

Country Link
US (2) US9314475B2 (pt)
EP (3) EP3789030A1 (pt)
JP (8) JP2011515473A (pt)
KR (3) KR101893740B1 (pt)
CN (1) CN102046177B (pt)
AU (1) AU2009229174A1 (pt)
BR (2) BRPI0909211B8 (pt)
CA (2) CA2984301C (pt)
CL (1) CL2010000281A1 (pt)
CO (1) CO6300935A2 (pt)
CY (2) CY1120240T1 (pt)
DK (2) DK2271348T3 (pt)
EC (1) ECSP10010576A (pt)
ES (2) ES2674708T3 (pt)
HR (2) HRP20180836T1 (pt)
HU (2) HUE038257T2 (pt)
IL (1) IL208440A0 (pt)
LT (2) LT2271348T (pt)
MA (1) MA32275B1 (pt)
MX (1) MX2010010585A (pt)
NO (1) NO2271348T3 (pt)
NZ (1) NZ588428A (pt)
PL (2) PL3348258T3 (pt)
PT (2) PT2271348T (pt)
RU (1) RU2010144130A (pt)
SI (2) SI2271348T1 (pt)
TR (1) TR201806893T4 (pt)
UA (2) UA109627C2 (pt)
WO (1) WO2009120389A1 (pt)
ZA (1) ZA201007013B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2717703A1 (en) * 2008-03-05 2009-09-11 Paratek Pharmaceuticals, Inc. Minocycline compounds and methods of use thereof
TW202216656A (zh) * 2008-05-19 2022-05-01 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體
KR101799304B1 (ko) 2010-05-12 2017-11-20 렘펙스 파머수티클스 인코퍼레이티드 테트라사이클린 조성물
BR112018072559A2 (pt) * 2016-05-02 2019-02-19 Paratek Pharmaceuticals, Inc. método de tratar infecção do trato urinário.
US10166912B2 (en) 2016-08-19 2019-01-01 Sl Corporation Automotive LED driving apparatus
BR112019008897A2 (pt) 2016-11-01 2019-08-13 Paratek Pharm Innc método para tratar pneumonia bacteriana adquirida na comunidade.
CA3111447A1 (en) 2018-09-04 2020-03-12 Paratek Pharmaceuticals, Inc. Methods of treating mycobacterial infections using tetracycline compounds
MX2022008103A (es) * 2019-12-30 2022-09-19 Deciphera Pharmaceuticals Llc Formulaciones de inhibidores de la cinasa amorfa y metodos de estas.
PT117254B (pt) 2021-05-26 2024-04-18 Hovione Farm S A Método de síntese de compostos 9-aminometil tetraciclinas

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2699054A (en) * 1953-10-09 1955-01-11 Lloyd H Conover Tetracycline
US2712517A (en) * 1954-03-03 1955-07-05 Bristol Lab Inc Production of tetracycline and substituted tetracyclines
US3019173A (en) * 1956-06-04 1962-01-30 American Cyanamid Co Method for preparing tetracycline
US2990331A (en) 1956-11-23 1961-06-27 Pfizer & Co C Stable solutions of salts of tetracyclines for parenteral administration
US3005023A (en) * 1957-04-05 1961-10-17 American Cyanamid Co Production of tetracycline
US2980584A (en) 1957-10-29 1961-04-18 Pfizer & Co C Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation
US2886595A (en) * 1958-09-30 1959-05-12 Bristol Lab Inc Tetracycline recovery
US3062717A (en) 1958-12-11 1962-11-06 Pfizer & Co C Intramuscular calcium tetracycline acetic or lactic acid carboxamide vehicle preparation
US3019260A (en) * 1959-05-13 1962-01-30 American Cyanamid Co Process for the catalytic reduction of 6-hydroxy hydronaphthacenes
FR1430859A (pt) * 1960-05-23 1966-05-25
US3165531A (en) 1962-03-08 1965-01-12 Pfizer & Co C 13-substituted-6-deoxytetracyclines and process utilizing the same
US3301899A (en) * 1963-11-27 1967-01-31 Bristol Myers Co Purification of tetracycline
US3454697A (en) 1965-06-08 1969-07-08 American Cyanamid Co Tetracycline antibiotic compositions for oral use
NL6607516A (pt) 1966-05-31 1967-12-01
DE1767891C3 (de) 1968-06-28 1980-10-30 Pfizer Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat
US3957980A (en) 1972-10-26 1976-05-18 Pfizer Inc. Doxycycline parenteral compositions
DE2442829A1 (de) 1974-09-06 1976-03-18 Merck Patent Gmbh Tetracyclische verbindungen und verfahren zu ihrer herstellung
US4018889A (en) 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
US4126680A (en) 1977-04-27 1978-11-21 Pfizer Inc. Tetracycline antibiotic compositions
US4837030A (en) 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
US5494903A (en) * 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
DE122006000058I1 (de) 1991-10-04 2007-01-18 Wyeth Corp 7-Substituierte-9-substituierte Amino-6-Demethyl-6-Deoxy-Tetracycline
US6465431B1 (en) * 1999-11-17 2002-10-15 Boston Life Sciences, Inc. Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
TR200000529T2 (tr) 1997-08-29 2000-08-21 Dsm N.V. İçinde eksipiyan olmayan granüller
KR100252699B1 (ko) * 1998-03-17 2000-12-01 강재헌 치주염 치료용 미노사이클린 조성물
ATE336238T1 (de) 1998-11-18 2006-09-15 Collagenex Pharm Inc Neue 4-dedimethylaminotetracyclinderivate
US6448323B1 (en) 1999-07-09 2002-09-10 Bpsi Holdings, Inc. Film coatings and film coating compositions based on polyvinyl alcohol
WO2001047554A1 (fr) * 1999-12-28 2001-07-05 Chugai Seiyaku Kabushiki Kaisha Compositions d'anticorps stables et preparations pour injection
EA013908B1 (ru) * 2000-07-07 2010-08-30 Трастис Оф Тафтс Коллидж Замещенные соединения миноциклина (варианты), фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния млекопитающего
US7553828B2 (en) * 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
WO2002072532A1 (en) 2001-03-13 2002-09-19 Paratek Pharmaceuticals, Inc. 7, 9-substituted tetracycline compounds
WO2002072031A2 (en) * 2001-03-14 2002-09-19 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as synergistic antifungal agents
AU2002256092C1 (en) 2001-04-05 2009-10-15 Collagenex Pharmaceuticals, Inc. Controlled delivery of tetracycline compounds and tetracycline derivatives
US8088820B2 (en) * 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
EP2329826A1 (en) * 2001-07-13 2011-06-08 Paratek Pharmaceuticals, Inc. Tetracyclines for the treatment of multiple sclerosis
JP2005526754A (ja) * 2002-03-08 2005-09-08 パラテック ファーマシューティカルズ インコーポレイテッド アミノメチル置換されたテトラサイクリン化合物
CN1390550A (zh) * 2002-07-25 2003-01-15 于航 盐酸米诺环素冻干粉针剂及其制备方法
CA2503446C (en) * 2002-10-24 2012-12-18 Paratek Pharmaceuticals, Inc. Methods of using substituted tetracycline compounds to modulate rna
WO2004038001A2 (en) * 2002-10-24 2004-05-06 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
US20040121003A1 (en) * 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
WO2004064728A2 (en) * 2003-01-16 2004-08-05 Paratek Pharmaceuticals, Inc. Use of specific tetracycline compounds in therapy
BRPI0407096A (pt) * 2003-02-03 2006-01-24 Neopharm Inc Taxano encapsulado em lipossomo estável, estéril e filtrável e outros fármacos antineoplásicos
WO2004078111A2 (en) * 2003-03-06 2004-09-16 Ranbaxy Laboratories Limited Extended release minocycline compositions and processes for their preparation
WO2004091513A2 (en) * 2003-04-10 2004-10-28 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
JP4738333B2 (ja) * 2003-07-09 2011-08-03 パラテック ファーマシューティカルズ インコーポレイテッド ９−アミノメチルテトラサイクリン化合物のプロドラッグ
CA2531728A1 (en) * 2003-07-09 2005-02-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
CA2553510C (en) * 2004-01-15 2012-09-25 Paratek Pharmaceuticals, Inc. Aromatic a-ring derivatives of tetracycline compounds
GB2414668B (en) * 2004-06-03 2009-07-29 Dexcel Ltd Tetracycline modified release delivery system
KR20130122988A (ko) 2005-03-14 2013-11-11 와이어쓰 엘엘씨 티게사이클린 조성물 및 이의 제조방법
EP2298324A1 (en) * 2006-01-24 2011-03-23 Paratek Pharmaceuticals, Inc. Methods of increasing oral bioavailability of tetracyclines
US20090246276A1 (en) * 2008-01-28 2009-10-01 Graham Jackson Pharmaceutical Compositions
CA2717703A1 (en) * 2008-03-05 2009-09-11 Paratek Pharmaceuticals, Inc. Minocycline compounds and methods of use thereof

Also Published As

Publication number Publication date
CY1123382T1 (el) 2021-12-31
RU2010144130A (ru) 2012-05-10
JP5940119B2 (ja) 2016-06-29
KR101835574B1 (ko) 2018-03-08
JP2018203778A (ja) 2018-12-27
ZA201007013B (en) 2013-11-27
JP2019196408A (ja) 2019-11-14
WO2009120389A1 (en) 2009-10-01
ECSP10010576A (es) 2010-12-30
EP2271348A1 (en) 2011-01-12
NZ588428A (en) 2012-08-31
UA109627C2 (uk) 2015-09-25
US20100056638A1 (en) 2010-03-04
HRP20201883T1 (hr) 2021-01-22
AU2009229174A1 (en) 2009-10-01
US9314475B2 (en) 2016-04-19
EP3789030A1 (en) 2021-03-10
LT2271348T (lt) 2018-06-25
KR101893740B1 (ko) 2018-08-30
KR101746228B1 (ko) 2017-06-12
HUE052201T2 (hu) 2021-04-28
PL2271348T3 (pl) 2018-08-31
PL3348258T3 (pl) 2021-03-08
HUE038257T2 (hu) 2018-10-29
IL208440A0 (en) 2010-12-30
JP6412521B2 (ja) 2018-10-24
DK3348258T3 (da) 2020-12-07
LT3348258T (lt) 2020-12-10
JP2025137721A (ja) 2025-09-19
CN102046177B (zh) 2012-12-19
EP2271348A4 (en) 2011-05-25
JP2021167355A (ja) 2021-10-21
BR122020011180B8 (pt) 2021-07-27
ES2674708T3 (es) 2018-07-03
JP2014221820A (ja) 2014-11-27
BRPI0909211B1 (pt) 2020-08-25
SI3348258T1 (sl) 2020-12-31
JP2011515473A (ja) 2011-05-19
CA2719751C (en) 2018-01-02
BR122020011180B1 (pt) 2021-03-23
UA122762C2 (uk) 2021-01-06
BRPI0909211A2 (pt) 2016-11-29
CO6300935A2 (es) 2011-07-21
JP6577645B2 (ja) 2019-09-18
JP2023144043A (ja) 2023-10-06
KR20160105532A (ko) 2016-09-06
WO2009120389A8 (en) 2010-05-14
EP3348258B1 (en) 2020-09-09
KR20180026799A (ko) 2018-03-13
PT2271348T (pt) 2018-04-16
HRP20180836T1 (hr) 2018-07-27
MX2010010585A (es) 2010-11-09
SI2271348T1 (en) 2018-08-31
CY1120240T1 (el) 2019-07-10
CA2984301C (en) 2020-10-27
EP3348258A1 (en) 2018-07-18
JP2016145260A (ja) 2016-08-12
CN102046177A (zh) 2011-05-04
NO2271348T3 (pt) 2018-08-25
ES2836448T3 (es) 2021-06-25
KR20110008057A (ko) 2011-01-25
CA2719751A1 (en) 2009-10-01
EP2271348B1 (en) 2018-03-28
CL2010000281A1 (es) 2012-03-30
TR201806893T4 (tr) 2018-06-21
CA2984301A1 (en) 2009-10-01
MA32275B1 (fr) 2011-05-02
US20160279151A1 (en) 2016-09-29
HK1257928A1 (en) 2019-11-01
DK2271348T3 (en) 2018-06-14
PT3348258T (pt) 2020-11-25

Similar Documents

Publication Publication Date Title
BRPI0909211B8 (pt) formulação oral em forma de comprimido de compostos de tetraciclina
ECSP099634A (es) Derivados de piridazinona útiles como inhibidores de glucano sintasa
PH12016500072A1 (en) Piperidinyl-indole derivatives complement factor b inhibitors and uses thereof
EA201170772A1 (ru) Органические соединения
GT201400111A (es) Triazolopiridinas sustituidas
UY32174A (es) Nuevos heterociclos sustituidos, composiciones farmaceuticas conteniendolos, procedimientos de preparacion y aplicaciones
BR112012023021A2 (pt) compostos de indazol e seus usos
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
MX2010014041A (es) Una forma cristalina de posaconazol.
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
MX340985B (es) Compuestos de n-heteroarilo.
CL2013002417A1 (es) Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
ECSP109984A (es) Composición farmacéutica mejorada que contiene dihidropiridina, antagonista del canal de calcio y el método para su preparación
ECSP12012338A (es) Triazolopiridinas sustituidas
GT201400261A (es) Solicitud pct face nacional novedosas n-piridinil amidas ciclicas sustituidas como inhibidores de quinasa
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
CL2017001483A1 (es) Formulación de relación fija de insulina glargina/lixisenatida
CO6321158A2 (es) Formulacion oral
AR095032A1 (es) Formulaciones de compuestos orgánicos, composición farmacéutica sólida comprimida por rodillo
BR112014009580A2 (pt) composição farmacêutica de omeprazol
UA110979C2 (uk) Рідка фармацевтична композиція, яка включає нітизинон
BR122016006880B8 (pt) forma de dosagem contendo pantoprazol como ingrediente ativo
CL2012003341A1 (es) Composicion farmaceutica de administracion oral que compende bendamustina o un ester, una sal o un solvato de la misma, y un excipiente que es un agente tensioactivo no ionico e hidrofilico; combinacion farmaceutica; y su uso para el tratamiento de leucemia linfocitica cronica y el mieloma multiple, entre otras enfermedades.
CL2011003123A1 (es) Compuestos derivados de ciclopentanamida sustituidos; composicion farmaceutica; proceso de obtencion; y uso en el tratamiento o la profilaxis de la diabetes, aterosclerosis, entre otras.
MX2020003660A (es) Derivados de acido gluconico para ser usados en el tratamiento y/o prevencion de infecciones microbianas.

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority

Free format text: PERDA DA PRIORIDADE US 61/040,398 DE 28/03/2008 REIVINDICADA NO PCT/US2009/001973 POR NAO CUMPRIMENTO DA EXIGENCIA PUBLICADA NA RPI 2389 DE 18/10/2016 DE MANEIRA SATISFATORIA. O DIREITO DE PRIORIDADE NAO PODE SER EXTRAPOLADO DE UM PEDIDO PARA OUTRO, DESTA FORMA, A CESSAO ENVIADA PARA O PEDIDO DE PATENTE US 12/414,612 DE 30/03/2009, MESMO ESTE REIVINDICANDO A PRIORIDADE DO PEDIDO US 61/040,398 DE 28/03/2008, NAO PODE SER CONSIDERADA VALIDA.

B12F Other appeals [chapter 12.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 25/08/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/03/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF